• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Archana M. Agarwal, MBBS, MD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English, Hindi

My clinical service responsibilities are in hematopathology, where I sign out molecular hematopathology, lymph node/bone marrow cases and flow cytometric evaluation for blood related disorders. My other clinical service responsibilities are in the Red Blood Cell Laboratory/Special Genetics Laboratory at ARUP, where I am the Co Medical Director. In this capacity, I am involved in review of patient test results, case sign out, review of quality control and quality assurance data, proficiency testing, and other clinical and administrative laboratory-related activities. I also provide consultation with clinical colleagues both locally and nationally in the area of hemoglobinopathies. My goal is to provide physicians with high quality test results and to give them my consultative expertise. In the area of teaching, I act as the director for the hemoglobinopathy/ thalassemia and benign red blood cell disorders rotation for hematopathology fellows.

Specialties

  • Hematopathology
  • Flow Cytometry
  • Pathology, Anatomical

Board Certification and Academic Information

Academic Departments Pathology - Associate Professor (Clinical)
Academic Divisions Clinical Pathology
Board Certification American Board of Pathology (Clinical Path)
American Board of Pathology (Sub: Anatomic Path)
American Board of Pathology (Sub: Hematology)
American Board of Pathology (Sub: Molecular Genetic Pathology)
National Board of Medical Examiners

My clinical service responsibilities are in hematopathology, where I sign out molecular hematopathology, lymph node/bone marrow cases and flow cytometric evaluation for blood related disorders. My other clinical service responsibilities are in the Red Blood Cell Laboratory/Special Genetics Laboratory at ARUP, where I am the Co Medical Director. In this capacity, I am involved in review of patient test results, case sign out, review of quality control and quality assurance data, proficiency testing, and other clinical and administrative laboratory-related activities. I also provide consultation with clinical colleagues both locally and nationally in the area of hemoglobinopathies. My goal is to provide physicians with high quality test results and to give them my consultative expertise. In the area of teaching, I act as the director for the hemoglobinopathy/ thalassemia and benign red blood cell disorders rotation for hematopathology fellows.

Academic Locations

ARUP Laboratories

801-583-2787

500 S Chipeta Way
G-04
Salt Lake City, UT  84108

Board Certification and Academic Information

Academic Departments Pathology - Associate Professor (Clinical)
Academic Divisions Clinical Pathology
Board Certification American Board of Pathology (Clinical Path)
American Board of Pathology (Sub: Anatomic Path)
American Board of Pathology (Sub: Hematology)
American Board of Pathology (Sub: Molecular Genetic Pathology)
National Board of Medical Examiners

Education History

Fellowship University of Utah School of Medicine, Department of Pathology
Molecular Genetic Pathology
Fellow
Residency University of Utah School of Medicine, Department of Pathology
Anatomic and Clinical
Resident
Fellowship University of Utah School of Medicine
Hematopathology
Fellow
Residency University of Utah School of Medicine, Department of Pathology
Anatomic and Clinical
Resident
Postdoctoral Fellowship University of Iowa
Research Scholar
Postdoctoral Fellow
Professional Medical Delhi University
Pathology
M.D.
Professional Medical Assam Medical College
Medicine
M.B.B.S.

Selected Publications - Journal Articles

Journal Article

  1. Lozano-Chinga M, Draper L, George TI, Agarwal AM, Dansie DM, Maese L (2020). Bone marrow necrosis in pediatric malignancies: 10-Year retrospective review and review of literature. Pediatr Blood Cancer, 68(3), e28806.
  2. Iglesias Cardenas F, Agarwal AM, Vagher J, Maese L, Fluchel M, Afify Z (2021). Two Clonally Distinct B-Cell Lymphomas Reveal the Diagnosis of XLP1 in a Male Child and His Asymptomatic Male Relatives: Case Report and Review of the Literature. (Epub ahead of print) J Pediatr Hematol Oncol.
  3. Bahr TM, Lozano-Chinga M, Agarwal AM, Meznarich JA, Gerday E, Smoot JL, Taylor A, Christensen RD (2020). Dizygotic twins with prolonged jaundice and microcytic, hypochromic, hemolytic anemia with pyropoikilocytosis. Blood Cells Mol Dis, 85, 102462.
  4. Rets AV, Reading NS, Agarwal AM (2020). δ-Globin Chain Variants Associated with Decreased Hb A2 Levels: A National Reference Laboratory Experience. Hemoglobin, 44(6), 438-441.
  5. Bahr TM, Agarwal AM, Christensen RD (2020). Does heterozygosity for UGT1A1 *28 convey increased risk for severe neonatal jaundice? (Epub ahead of print) J Perinatol.
  6. Cowman SJ, Fuja DG, Liu XD, Tidwell RSS, Kandula N, Sirohi D, Agarwal AM, Emerson LL, Tripp SR, Mohlman JS, Stonhill M, Garcia G, Conley CJ, Olalde AA, Sargis T, Ramirez-Torres A, Karam JA, Wood CG, Sircar K, Tamboli P, Boucher K, Maughan B, Spike BT, Ho TH, Agarwal N, Jonasch E, Koh MY (2020). Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer. Clin Cancer Res, 26(18), 4970-4982.
  7. T, Knudsen MC, Lozano-Chinga M, Agarwal AM, Meznarich J Ohls RK, Christensen RD (2020). Infantile Pyknocytosis: End tidal-CO, %Micro-R measurements, next generation sequencing, and transfusion-avoidance with darbepoetin. Biomedicine hub, 5.
  8. Agarwal AM, Rets A (2020). Laboratory approach to investigation of anemia with a focus on pyruvate kinase deficiency. Int J Lab Hematol, 42 Suppl 1, 107-112.
  9. Samha L, Sirdah MM, Reading NS, Karmi B, Agarwal AM (2020). Molecular Understanding of Severe Cases of β-Thalassemia in the Nablus Region, West Bank, Palestine. Hemoglobin, 44(2), 128-130.
  10. He L, Rockwood AL, Agarwal AM, Anderson LC, Weisbrod CR, Hendrickson CL, Marshall AG (2020). Top-down proteomics-a near-future technique for clinical diagnosis? Ann Transl Med, 8(4), 136.
  11. Patel AB, Franzini A, Leroy E, Kim SJ, Pomicter AD, Genet L, Xiao M, Yan D, Ahmann JM, Agarwal AM, Clair P, Addada J, Lambert J, Salmon M, Gleich GJ, Cross NCP, Constantinescu SN, OHare T, Prchal JT, Deininger MW (2019). JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera. Blood, 134(26), 2388-2398.
  12. He L, Rockwood AL, Agarwal AM, Anderson LC, Weisbrod CR, Hendrickson CL, Marshall AG (2019). Diagnosis of Hemoglobinopathy and β-Thalassemia by 21 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometry and Tandem Mass Spectrometry of Hemoglobin from Blood. Clin Chem, 65(8), 986-994.
  13. Rets A, Clayton AL, Christensen RD, Agarwal AM (2019). Molecular diagnostic update in hereditary hemolytic anemia and neonatal hyperbilirubinemia. Int J Lab Hematol, 41 Suppl 1, 95-101.
  14. Stenehjem DD, Hahn AW, Gill DM, Albertson D, Gowrishankar B, Merriman J, Agarwal AM, Thodima V, Harrington EB, Au TH, Maughan BL, Houldsworth J, Pal SK, Agarwal N (2019). Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma. PLoS ONE, 14(1), e0210415.
  15. Bahr TM, Christensen RD, Agarwal AM, George TI, Bhutani VK (2019). The Neonatal Acute Bilirubin Encephalopathy Registry (NABER): Background, Aims, and Protocol. Neonatology, 115(3), 242-246.
  16. Christensen RD, Agarwal AM, George TI, Bhutani VK, Yaish HM (2018). Acute neonatal bilirubin encephalopathy in the State of Utah 2009-2018. Blood Cells Mol Dis, 72, 10-13.
  17. Hahn AW, Gill DM, Maughan B, Agarwal A, Arjyal L, Gupta S, Streeter J, Bailey E, Pal SK, Agarwal N (2017). Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications. Oncotarget, 8(20), 33614-33620.
  18. Agarwal AM, Liew MA, Nussenzveig RH, Sangle N, Heikal N, Yaish H, Christensen R (2015). Improved harmonization of eosin-5-maleimide binding test across different instruments and age groups. Cytometry B Clin Cytom, 90(6), 512-516.
  19. Reading NS, Shooter C, Song J, Miller R, Agarwal A, Lanikova L, Clark B, Thein SL, Divoky V, Prchal JT (2016). Loss of Major DNase I Hypersensitive Sites in Duplicated β-globin Gene Cluster Incompletely Silences HBB Gene Expression. Hum Mutat, 37(11), 1153-1156.
  20. Tantravahi SK, Albertson D, Agarwal AM, Ravulapati S, Poole A, Patel SB, Hawatmeh JS, Straubhar AM, Liu T, Stenehjem DD, Agarwal N (2015). Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma. J Oncol, 2015, 181926.
  21. Yaish HM, Christensen RD, Agarwal A (2013). A neonate with Coombs-negative hemolytic jaundice with spherocytes but normal erythrocyte indices: a rare case of autosomal-recessive hereditary spherocytosis due to alpha-spectrin deficiency. J Perinatol, 33(5), 404-6.
  22. Patel JC, Maughan BL, Agarwal AM, Batten JA, Zhang TY, Agarwal N (2013). Emerging molecularly targeted therapies in castration refractory prostate cancer. Prostate Cancer, 2013, 981684.
  23. Vanhille DL, Nussenzveig RH, Glezos C, Perkins S, Agarwal AM (2012). Best practices for use of the HEMOX analyzer in the clinical laboratory: quality control determination and choice of anticoagulant. Lab Hematol, 18(3), 17-9.

Case Report

  1. Bahr TM, Lozano-Chinga M, Agarwal AM, Meznarich JA, Yost CC, Li P, Reading NS, Prchal JT, Christensen RD (2020). A Novel Variant in G6PD (c.1375C>G) Identified from a Hispanic Neonate with Extreme Hyperbilirubinemia and Low G6PD Enzymatic Activity. Neonatology, 117(4), 532-535.

Editorial

  1. Agarwal AM (2019). Ankyrin Mutations in Hereditary Spherocytosis. Acta Haematol, 141(2), 63-64.

Global Impact

Education History

Professional Medical Delhi University
Pathology
M.D.
Professional Medical Assam Medical College
Medicine
M.B.B.S.

Site Links

  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • The Imagine Perfect Care Program

Helpful Links

  • Referring Providers
  • Find an Interpreter
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2021 University of Utah Health